Mediclin AG

MED.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MED.DE stands at 143.5M. In comparison, FRE.DE has a market cap of 24B. Regarding current trading prices, MED.DE is priced at €3.02, while FRE.DE trades at €42.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MED.DE currently has a P/E ratio of 5.49, whereas FRE.DE's P/E ratio is 22.78. In terms of profitability, MED.DE's ROE is +0.12%, compared to FRE.DE's ROE of +0.02%. Regarding short-term risk, MED.DE is more volatile compared to FRE.DE. This indicates potentially higher risk in terms of short-term price fluctuations for MED.DE.

MED.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MED.DE stands at 143.5M. In comparison, FME.DE has a market cap of 14.2B. Regarding current trading prices, MED.DE is priced at €3.02, while FME.DE trades at €48.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MED.DE currently has a P/E ratio of 5.49, whereas FME.DE's P/E ratio is 22.89. In terms of profitability, MED.DE's ROE is +0.12%, compared to FME.DE's ROE of +0.04%. Regarding short-term risk, MED.DE is more volatile compared to FME.DE. This indicates potentially higher risk in terms of short-term price fluctuations for MED.DE.

MED.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MED.DE stands at 143.5M. In comparison, BZ7A.F has a market cap of 2.7B. Regarding current trading prices, MED.DE is priced at €3.02, while BZ7A.F trades at €3.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MED.DE currently has a P/E ratio of 5.49, whereas BZ7A.F's P/E ratio is 14.96. In terms of profitability, MED.DE's ROE is +0.12%, compared to BZ7A.F's ROE of +0.28%. Regarding short-term risk, MED.DE is more volatile compared to BZ7A.F. This indicates potentially higher risk in terms of short-term price fluctuations for MED.DE.

MED.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MED.DE stands at 143.5M. In comparison, RHK.DE has a market cap of 796.6M. Regarding current trading prices, MED.DE is priced at €3.02, while RHK.DE trades at €11.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MED.DE currently has a P/E ratio of 5.49, whereas RHK.DE's P/E ratio is 19.83. In terms of profitability, MED.DE's ROE is +0.12%, compared to RHK.DE's ROE of +0.03%. Regarding short-term risk, MED.DE is more volatile compared to RHK.DE. This indicates potentially higher risk in terms of short-term price fluctuations for MED.DE.

MED.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MED.DE stands at 143.5M. In comparison, M12.DE has a market cap of 276.8M. Regarding current trading prices, MED.DE is priced at €3.02, while M12.DE trades at €14.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MED.DE currently has a P/E ratio of 5.49, whereas M12.DE's P/E ratio is 17.55. In terms of profitability, MED.DE's ROE is +0.12%, compared to M12.DE's ROE of +0.15%. Regarding short-term risk, MED.DE is less volatile compared to M12.DE. This indicates potentially lower risk in terms of short-term price fluctuations for MED.DE.

MED.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MED.DE stands at 143.5M. In comparison, LIK.DE has a market cap of 116.7M. Regarding current trading prices, MED.DE is priced at €3.02, while LIK.DE trades at €398.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MED.DE currently has a P/E ratio of 5.49, whereas LIK.DE's P/E ratio is 37.48. In terms of profitability, MED.DE's ROE is +0.12%, compared to LIK.DE's ROE of +0.26%. Regarding short-term risk, MED.DE is more volatile compared to LIK.DE. This indicates potentially higher risk in terms of short-term price fluctuations for MED.DE.

MED.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MED.DE stands at 143.5M. In comparison, V3V.DE has a market cap of 72.9M. Regarding current trading prices, MED.DE is priced at €3.02, while V3V.DE trades at €4.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MED.DE currently has a P/E ratio of 5.49, whereas V3V.DE's P/E ratio is -6.06. In terms of profitability, MED.DE's ROE is +0.12%, compared to V3V.DE's ROE of +0.11%. Regarding short-term risk, MED.DE is more volatile compared to V3V.DE. This indicates potentially higher risk in terms of short-term price fluctuations for MED.DE.

MED.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MED.DE stands at 143.5M. In comparison, MAK.DE has a market cap of 30.4M. Regarding current trading prices, MED.DE is priced at €3.02, while MAK.DE trades at €1.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MED.DE currently has a P/E ratio of 5.49, whereas MAK.DE's P/E ratio is -4.39. In terms of profitability, MED.DE's ROE is +0.12%, compared to MAK.DE's ROE of +0.10%. Regarding short-term risk, MED.DE is more volatile compared to MAK.DE. This indicates potentially higher risk in terms of short-term price fluctuations for MED.DE.

MED.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MED.DE stands at 143.5M. In comparison, UOM.MU has a market cap of 4.9M. Regarding current trading prices, MED.DE is priced at €3.02, while UOM.MU trades at €6.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MED.DE currently has a P/E ratio of 5.49, whereas UOM.MU's P/E ratio is 41.00. In terms of profitability, MED.DE's ROE is +0.12%, compared to UOM.MU's ROE of +0.03%. Regarding short-term risk, MED.DE is more volatile compared to UOM.MU. This indicates potentially higher risk in terms of short-term price fluctuations for MED.DE.